8 Einträge gefunden

1. VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients

   1. Kuerti, Sascha
   2. Oliveira-Ferrer, Leticia
   3. Milde-Langosch, Karin
   4. Schmalfeldt, Barbara
   5. Legler, Karen
   6. Woelber, Linn
   7. Prieske, Katharina

   2017 - Forschungsinformationssystem des UKE
2. Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer

   1. Prieske, Katharina
   2. Prieske, Stefan
   3. Joosse, Simon A
   4. Trillsch, Fabian
   5. Grimm, Donata
   6. Burandt, Eike
   7. Mahner, Sven

   2017 - Forschungsinformationssystem des UKE
3. Sarcopenia in Advanced Serous Ovarian Cancer

   1. Bronger, Holger
   2. Hederich, Philipp
   3. Hapfelmeier, Alexander
   4. Metz, Stephan
   5. Noël, Peter B
   6. Kiechle, Marion
   7. Schmalfeldt, Barbara

   2017 - Forschungsinformationssystem des UKE
4. Role of HYAL1 expression in primary breast cancer in the formation of brain metastases

   1. Witzel, Isabell
   2. Marx, Anna K
   3. Müller, Volkmar
   4. Wikman, Harriet
   5. Matschke, Jakob
   6. Schumacher, Udo
   7. Stürken, Christine

   2017 - Forschungsinformationssystem des UKE
5. Quality of life in patients with recurrent breast cancer after second breast-conserving therapy in comparison with mastectomy: the German experience

   1. Jendrian, Svenja
   2. Steffens, Katharina
   3. Schmalfeldt, Barbara
   4. Laakmann, Elena
   5. Bergelt, Corinna
   6. Witzel, Isabell

   2017 - Forschungsinformationssystem des UKE
6. Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia

   1. Woelber, Linn
   2. Breuer, Julia
   3. Meyer, Thomas
   4. Vettorazzi, Eik
   5. Prieske, Katharina
   6. Bohlmann, Inga
   7. Busch, Chia-Jung

   2017 - Forschungsinformationssystem des UKE
7. Current Status of Targeted Treatment in Breast Cancer, Zielgerichtete Therapie des Mammakarzinoms

   1. Seiffert, Katharina
   2. Schmalfeldt, Barbara
   3. Müller, Volkmar

   2017 - Forschungsinformationssystem des UKE
8. Increased PDGFR-beta and VEGFR-2 protein levels are associated with resistance to platinum-based chemotherapy and adverse outcome of ovarian cancer patients

   1. Avril, Stefanie
   2. Dincer, Yasemin
   3. Malinowsky, Katharina
   4. Wolff, Claudia
   5. Gündisch, Sibylle
   6. Hapfelmeier, Alexander
   7. Boxberg, Melanie

   2017 - Forschungsinformationssystem des UKE